Compare
Johnson & Johnson vs McKesson (JNJ vs MCK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and McKesson (MCK) +25.6%; so far this year the figures are +33.5% and +29.3%.
Johnson & Johnson is the larger company by market value, about 5.4 times the size of McKesson.
On trailing earnings, JNJ trades at 41.9 times and MCK at 27.3 times.
Revenue grew +7.8% at JNJ and +8.2% at MCK over the last year.
JNJ yields 1.91%. MCK yields 0.32%.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | MCK | |
|---|---|---|
| Price | $276.22 | $1,060.84 |
| 1-day | +1.43% | -1.04% |
| YTD | +33.47% | +29.32% |
| 1 year | +48.51% | +25.65% |
| 3 years | +85.77% | +130.82% |
| Market cap | $665.0B | $122.5B |
| P/E | 41.9 | 27.3 |
| P/S | 6.69 | 0.29 |
| P/B | 8.16 | — |
| Revenue growth | +7.80% | +8.20% |
| EPS growth | -36.40% | +21.20% |
| Gross margin % | 67.6 | 3.7 |
| Net margin % | 16.2 | 1.1 |
| ROE % | 19.7 | — |
| Debt / equity | 0.55 | — |
| FCF yield % | 3.1 | 5.8 |
| Dividend yield % | 1.91 | 0.32 |
| Beta | -0.09 | -0.17 |
| RSI (14) | 59.4 | 70.2 |
| Technical rating |